[关键词]
[摘要]
目的探讨左卡尼汀纠正维持性血液透析患者肾性贫血效果及对内皮素和左室重构的影响。方法将安阳市人民医院自2010年11月-2014年11月收治的维持血液透析6个月以上的尿毒症患者206例作为研究对象,随机分为研究组和对照组各103例,对照组患者给予促红细胞生成素,研究组患者在对照组治疗的基础上静脉推注左卡尼汀注射液,治疗6个月后,检测血红蛋白(Hb)、红细胞比容(HCT),测定血清内皮素(ET),并由有经验的超声诊断医师测量左心房内径(LAD)、左心室收缩末期内径(LVDs)、左心室舒张末期内径(LVDd)的变化等。结果治疗后两组Hb和HCT均明显升高,ET水平明显降低,与同组治疗前比较差异具有统计学意义(P<0.05);且研究组患者以上指标的改变水平显著优于对照组,组间比较差异具有统计学意义(P<0.05);两组患者治疗后LAD、LVDs、LVDd均发生不同程度的降低,且研究组显著低于对照组,组间比较差异具有统计学意义(P<0.05)。结论左卡尼汀联合促红细胞生成素治疗维持性血液透析患者肾性贫血可提高治疗效果,降低血浆内皮素水平,有效改善或抑制左室重构的发生和发展,有效预防心衰的发生,效果显著,可推广使用。
[Key word]
[Abstract]
Objective To investigate the effect of L-carnitine on the anemia of renal anemia and its effect on endothelin and left ventricular remodeling in maintenance hemodialysis patients. Methods 206 patients with uremia who underwent hemodialysis for more than 6 months from November 2010 to November 2014 were randomly divided into study group and control group (n=103), control group (n=103). Patients in the study group were treated with intravenous injection of levocarnitine injection on the basis of the control group. After 6 months of treatment, the clinical curative effect of the two groups was observed. Results After treatment, the levels of Hb and HCT were significantly increased, ET levels were significantly reduced, in which the change of patients in the study group was significantly better than the control group (P < 0.05); LAD, LVDs and LVDd of the two groups were different (P < 0.05). The difference between the two groups was statistically significant (P < 0.05). Conclusion L-carnitine combined with erythropoietin in the treatment of renal hemodialysis patients with renal anemia can improve the therapeutic effect, reduce plasma endothelin levels, effectively improve or inhibit the occurrence and development of left ventricular remodeling, effective prevention of heart failure, The effect is remarkable, can promote the use.
[中图分类号]
[基金项目]